Associate Director
Alexion
Associate Director
Alexion
Global biopharmaceuticals focusing on rare diseases
Introduction:
This role offers a unique opportunity to lead communication and change management efforts within Alexion-Rare Disease Unit (RDU) IT. As the Associate Director of RDU IT Communications and Change Management, you will develop and execute strategies that enhance employee engagement, foster innovation, and drive performance during RDU IT’s transformational journey. You will ensure clear and impactful communication of RDU IT initiatives, including digital innovation and AI innovation, aligning with broader organizational goals.
Working closely with the Head of RDU IT, you will deliver creative, visually engaging presentations that reflect AstraZeneca and Alexion co-branding, while guiding stakeholders on best communication practices. Building trust, credibility, and collaboration is essential, as is the ability to deliver effective multi-channel communications. A strong background in Pharma, IT, and digital communications, coupled with excellent writing, planning, and project management skills, is critical for success.
Accountabilities:
Essential Skills/Experience:
Desirable Skills/Experience:
The annual base pay (or hourly rate of compensation) for this position ranges from 128,937.6 to 193,406.4 USD. Our positions offer eligibility for various incentives—an opportunity to receive short-term incentive bonuses, equity-based awards for salaried roles and commissions for sales roles. Benefits offered include qualified retirement programs, paid time off (i.e., vacation, holiday, and leaves), as well as health, dental, and vision coverage in accordance with the terms of the applicable plans.
When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That's why we work, on average, a minimum of three days per week from the office. But that doesn't mean we're not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
Why AstraZeneca:
Here, you are trusted to take accountability and make change real—pairing scientific ambition with digital innovation to speed therapies to patients. You will work with expert partners across disciplines, using data, automation, and practical problem-solving to reimagine how critical materials flow through a complex, regulated network. We move decisively and learn fast, valuing kindness alongside ambition, so you can contribute boldly, grow your craft, and see the impact of your decisions reflected in patient outcomes and enterprise progress.
Call to Action:
If you are ready to design, lead, and scale a disciplined, data-driven trade compliance operation that keeps cell therapies moving to patients, take the next step and share your story with us today.
#LI-Hybrid
Date Posted
04-Nov-2026Closing Date
29-Nov-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and employees. In furtherance of that mission, we welcome and consider applications from all qualified candidates, regardless of their protected characteristics. If you have a disability or special need that requires accommodation, please complete the corresponding section in the application form.
Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.
Explore more opportunities at Alexion